Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nete Huus
Observed name:
N. Huus
Institution:
NMD Pharma A/S (Denmark)
Observed institution:
NMD Pharma A/S (Denmark)
ORCID:
0000-0002-5737-6207
Observed ORCID:
0000-0002-5737-6207
OpenAlex ID:
A5094199119
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis
2024
·
Martin Skov
, Titia Q. Ruijs
, et al.
·
Science Translational Medicine
·
37
PDF
The muscle atrophic phenotype of MuSK myasthenia gravis: Insights from a preclinical rat model
2026
·
Jesper Emil Jakobsgaard
, Pernille Bogetofte Thomasen
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
566P ClC-1 chloride channel inhibition improves disease symptoms and survival in a rat model of muscle-specific kinase (MuSK) myasthenia gravis
2024
·
M. Skals
, J. Morgen
, et al.
·
Neuromuscular Disorders
Show more works
View as search
Works count:
3
Citation count:
37
H-index:
1
I10-index:
1
Year
Topic
Type
